Adage Capital Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,500,000	Closed	-$10.8M	–	974
2025 Q3	$10.8M	Buy	+1,500,000	New	+$78.2M	0.02%	614
2025 Q1	–	Sell	-155,000	Closed	-$8.39M	–	905
2024 Q4	$8.39M	Sell	155,000 -350,000	-69%	-$17.9M	0.01%	647
2024 Q3	$25.5M	Sell	505,000 -1,320,000	-72%	-$61.9M	0.05%	392
2024 Q2	$80.2M	Sell	1,825,000 -459,913	-20%	-$19.5M	0.15%	145
2024 Q1	$115M	Buy	2,284,913 +759,196	+50%	+$41.2M	0.22%	95
2023 Q4	$92.1M	Sell	1,525,717 -426,986	-22%	-$22M	0.19%	120
2023 Q3	$111M	Buy	1,952,703 +580,375	+42%	+$32M	0.25%	86
2023 Q2	$70M	Sell	1,372,328 -296,543	-18%	-$7.98M	0.15%	154
2023 Q1	$35.7M	Buy	+1,668,871	New	+$28.1M	0.08%	287
2022 Q1	–	Sell	-1,011,589	Closed	-$10M	–	1112
2021 Q4	$10M	Hold	1,011,589	–	–	0.02%	696
2021 Q3	$10.1M	Hold	1,011,589	–	–	0.02%	680
2021 Q2	$10.5M	Hold	1,011,589	–	–	0.02%	676
2021 Q1	$10.3M	Hold	1,011,589	–	–	0.02%	664
2020 Q4	$11.5M	Buy	+1,011,589	New	+$10.7M	0.03%	557